
    
      Methods:

      Adult patients with liver cirrhosis or stigmata of chronic liver disease presenting with
      hematemesis and or melena within previous 12 hours were randomized in a double blind trial to
      receive either 125 mg erythromycin or placebo 30 minutes before endoscopy. The primary end
      points were endoscopic visibility assessed by objective scoring system & mean endoscopy
      duration. Secondary end points were need for repeat endoscopy and blood transfusions within
      24 hours of first endoscopy , endoscopy related complications and length of hospital stay.
    
  